Altimmune (ALT) CEO Garg received 4,105 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Vipin K Garg (President and CEO at Altimmune Inc., ALT) reported that they received 4,105 shares, and acquired 62,270 shares, and gave up 27,214 shares at an average $6.79 to cover taxes or an exercise price between Jan 30, 2025 and Feb 2, 2025. After these transactions the filing shows 355,082 shares held directly.
- Reporting person
- Garg Vipin K
- Role
- President and CEO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 30, 2025 | Exercise or conversion of a derivative (M) | Common Stock, par value $0.00012 | +26,775 | - | - | 342,696 direct |
| Jan 30, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock, par value $0.00011 | -11,701 | $7.00 | $81.9K | 330,995 direct |
| Jan 31, 2025 | Grant or award (A) | Common Stock, par value $0.00013, 4 | +4,105 | $5.18 | $21.3K | 335,100 direct |
| Feb 1, 2025 | Exercise or conversion of a derivative (M) | Common Stock, par value $0.00012 | +16,545 | - | - | 351,645 direct |
| Feb 1, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock, par value $0.00011 | -7,231 | $6.64 | $48K | 344,414 direct |
| Feb 2, 2025 | Exercise or conversion of a derivative (M) | Common Stock, par value $0.00012 | +18,950 | - | - | 363,364 direct |
| Feb 2, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock, par value $0.00011 | -8,282 | $6.64 | $55K | 355,082 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 30, 2025 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 26,775 Common Stock, par value $0.00011, 5 | +26,775 | - | - | 53,550 direct |
| Feb 1, 2025 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 16,545 Common Stock, par value $0.00011, 6 | +16,545 | - | - | 0 direct |
| Feb 2, 2025 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 18,950 Common Stock, par value $0.00011, 7 | +18,950 | - | - | 18,950 direct |
Holdings before and after
- Common Stock, par value $0.0001: 315,921 to 355,082 direct
- Restricted Stock Units: 26,775 to 18,950 direct
Footnotes from the filing
- 1. Each Restricted Stock Unit ( RSU ) represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- 2. Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- 3. These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ( ESPP ). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025.
- 4. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024.
- 5. The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
- 6. The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Garg report in this ALT Form 4?
Vipin K Garg (President and CEO at Altimmune Inc., ALT) reported that they received 4,105 shares, and acquired 62,270 shares, and gave up 27,214 shares at an average $6.79 to cover taxes or an exercise price between Jan 30, 2025 and Feb 2, 2025. After these transactions the filing shows 355,082 shares held directly.
How many ALT shares does Garg hold after this filing?
The filing shows 355,082 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ALT
Earlier insider filings at ALT
- Feb 4, 2025Chief Medical Officer Harris Matthew Scott converted options into 23,216 shares, covered exercise/tax liability with 7,990 shares and was granted 1,905 shares, increasing direct ownership by 26% to 81,856 units (SEC Form 4)
- Feb 4, 2025Chief Business Officer Jordt Raymond M was granted 2,614 shares, increasing direct ownership by 8% to 34,902 units (SEC Form 4)
- Feb 4, 2025Chief Scientific Officer Roberts M Scot converted options into 23,216 shares, covered exercise/tax liability with 6,826 shares and was granted 3,184 shares, increasing direct ownership by 36% to 73,220 units (SEC Form 4)
- Jan 29, 2025Chief Scientific Officer Roberts M Scot converted options into 14,600 shares and covered exercise/tax liability with 4,264 shares, increasing direct ownership by 24% to 53,646 units (SEC Form 4)
- Jan 29, 2025Chief Business Officer Jordt Raymond M converted options into 14,600 shares and covered exercise/tax liability with 3,862 shares, increasing direct ownership by 50% to 32,288 units (SEC Form 4)
Quantisnow market dataNASDAQ
ALT
Altimmune Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for ALT
Full ALT profile on Quantisnow Follow ALT and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time